Skip to main content
Equibles
DNTH logo

DNTH · Dianthus Therapeutics, Inc. /DE/

Track DNTH — free

Use DNTH with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about DNTH

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$115.96 +6.36 (+5.80%) At close · Aug 14
Market Cap
$6.49B
Shares
55.93M

Dianthus Therapeutics, Inc. Earnings Call Transcripts

Every quarterly earnings call for Dianthus Therapeutics, Inc. (DNTH) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $ −$23.24M '19 Q4 20-01-13 · $ −$20.01M '20 Q1 20-05-07 LATEST ▼78.6% $284,000 −$64.43M '25 Q4 26-03-09
Conference
Investor event
2026-06-09
Goldman Sachs 47th Annual Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-03-09
Dianthus Therapeutics, Inc. /DE/ Q4 FY2025 Earnings Call
Revenue
$284,000*
▼ 78.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Conference
Investor event
2026-03-03
TD Cowen 46th Annual Health Care Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-01-12
44th Annual J.P. Morgan Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY22 · Q2
2022-08-04
Dianthus Therapeutics, Inc. /DE/ Q2 FY2022 Earnings Call
Diluted EPS
$-0.29
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-01-10
Dianthus Therapeutics, Inc. /DE/ Q4 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q4
2021-01-11
Dianthus Therapeutics, Inc. /DE/ Q4 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q1
2020-05-07
Dianthus Therapeutics, Inc. /DE/ Q1 FY2020 Earnings Call
Revenue
$
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-01-13
Dianthus Therapeutics, Inc. /DE/ Q4 FY2019 Earnings Call
Revenue
$
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–9 of 9 earnings calls
Key facts CIK 1690585 CUSIP 252828108 13F (30d) 263 filings 259 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)